Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
LCC Medical Research Institute, LLC
2727
mi
from 98109
Miami, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
LCC Medical Research Institute, LLC
2727
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Oceane7 Clinical Research, Llc
2727
mi
from 98109
Miami, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Oceane7 Clinical Research, Llc
2727
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
RM Medical Research, Inc.
2725
mi
from 98109
Miami, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
RM Medical Research, Inc.
2725
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
IMIC
2733
mi
from 98109
Palmetto Bay, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
IMIC
2733
mi
from 98109
Palmetto Bay, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Clinical Research Trials of Florida, Inc.
2524
mi
from 98109
Tampa, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Clinical Research Trials of Florida, Inc.
2524
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Meridien Research
2527
mi
from 98109
Tampa, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Meridien Research
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Heartland Research Associates, LLC
1451
mi
from 98109
Augusta, KA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Heartland Research Associates, LLC
1451
mi
from 98109
Augusta, KA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Dermatology Specialists Research
1939
mi
from 98109
Louisville, KY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Dermatology Specialists Research
1939
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
DermResearch, PLLC
1941
mi
from 98109
Louisville, KY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
DermResearch, PLLC
1941
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Core Healthcare Group
mi
from 98109
Cerritos, LA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Core Healthcare Group
mi
from 98109
Cerritos, LA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
DelRicht Research
2095
mi
from 98109
New Orleans, LA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
DelRicht Research
2095
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
MediSearch Clinical Trials
1469
mi
from 98109
Saint Joseph, MO
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
MediSearch Clinical Trials
1469
mi
from 98109
Saint Joseph, MO
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Quality Clinical Research, Inc.
1361
mi
from 98109
Omaha, NE
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Quality Clinical Research, Inc.
1361
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
eStudySite
876
mi
from 98109
Las Vegas, NV
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
eStudySite
876
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
ActivMed Practices & Research, Inc.
2477
mi
from 98109
Portsmouth, NH
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
ActivMed Practices & Research, Inc.
2477
mi
from 98109
Portsmouth, NH
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
New York Clinical Trials
2401
mi
from 98109
Manhattan, NY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
New York Clinical Trials
2401
mi
from 98109
Manhattan, NY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Derm Research Center of New York, Inc.
2435
mi
from 98109
Stony Brook, NY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Derm Research Center of New York, Inc.
2435
mi
from 98109
Stony Brook, NY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Dermatology Consulting Services
2290
mi
from 98109
High Point, NC
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Dermatology Consulting Services
2290
mi
from 98109
High Point, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Wake Research Associates, LLC
2356
mi
from 98109
Raleigh, NC
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Wake Research Associates, LLC
2356
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Paddington Testing Co., Inc.
2372
mi
from 98109
Philadelphia, PA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Paddington Testing Co., Inc.
2372
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Palmetto Clinical Trial Services, LLC @ Greenville Dermatology
2240
mi
from 98109
Greenville, SC
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Palmetto Clinical Trial Services, LLC @ Greenville Dermatology
2240
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Discover Research
1807
mi
from 98109
Bryan, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Discover Research
1807
mi
from 98109
Bryan, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
West Houston Clinical Research Services
1883
mi
from 98109
Houston, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
West Houston Clinical Research Services
1883
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Austin Institute for Clinical Research, Inc.
1766
mi
from 98109
Pflugerville, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Austin Institute for Clinical Research, Inc.
1766
mi
from 98109
Pflugerville, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Texas Dermatology and Laser Specialists
1787
mi
from 98109
San Antonio, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Texas Dermatology and Laser Specialists
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated:  10/4/2017
Stanford University
705
mi
from 98109
Stanford, CA
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated: 10/4/2017
Stanford University
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study
Status: Enrolling
Updated:  10/4/2017
Poudre Valley Health System
982
mi
from 98109
Fort Collins, CO
Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study
Status: Enrolling
Updated: 10/4/2017
Poudre Valley Health System
982
mi
from 98109
Fort Collins, CO
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Delaware/Christiana Care NCORP
2355
mi
from 98109
Newark, DE
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Delaware/Christiana Care NCORP
2355
mi
from 98109
Newark, DE
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Heartland NCORP
1735
mi
from 98109
Decatur, IL
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Heartland NCORP
1735
mi
from 98109
Decatur, IL
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Metro Minnesota NCORP
1386
mi
from 98109
Minneapolis, MN
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Metro Minnesota NCORP
1386
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
University of Rochester
2161
mi
from 98109
Rochester, NY
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
University of Rochester
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Columbus NCORP
2008
mi
from 98109
Columbus, OH
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Columbus NCORP
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Dayton Oncology Research Program
1964
mi
from 98109
Dayton, OH
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Dayton Oncology Research Program
1964
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Radiant Research, Inc.
1224
mi
from 98109
Tucson, AZ
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Radiant Research, Inc.
1224
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Johnson Dermatology
1660
mi
from 98109
Fort Smith, AR
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Johnson Dermatology
1660
mi
from 98109
Fort Smith, AR
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Dermatology Research of Arkansas
1778
mi
from 98109
Little Rock, AR
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Dermatology Research of Arkansas
1778
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Hull Dermatology, P.A.
1633
mi
from 98109
Rogers, AR
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Hull Dermatology, P.A.
1633
mi
from 98109
Rogers, AR
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Shahram Jacobs, M.D., Inc.
952
mi
from 98109
Encino, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Shahram Jacobs, M.D., Inc.
952
mi
from 98109
Encino, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
University of California, San Diego Dermatology Clinical Trials Unit
1053
mi
from 98109
La Jolla, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
University of California, San Diego Dermatology Clinical Trials Unit
1053
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Dermatology Research Associates
966
mi
from 98109
Los Angeles, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Dermatology Research Associates
966
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Laser and Dermatology Center
964
mi
from 98109
Marina del Rey, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Laser and Dermatology Center
964
mi
from 98109
Marina del Rey, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Integrated Research Group
980
mi
from 98109
Riverside, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Integrated Research Group
980
mi
from 98109
Riverside, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
University of California-Davis
627
mi
from 98109
Sacramento, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
University of California-Davis
627
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Therapeutics Clinical Research
1060
mi
from 98109
San Diego, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Therapeutics Clinical Research
1060
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
East Bay Psoriasis Treatment Center
681
mi
from 98109
San Ramon, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
East Bay Psoriasis Treatment Center
681
mi
from 98109
San Ramon, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Stanford University Dept of Dermatology
704
mi
from 98109
Stanford, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Stanford University Dept of Dermatology
704
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Solano Clinical Research, Dow Pharmaceutical Sciences
658
mi
from 98109
Vallejo, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Solano Clinical Research, Dow Pharmaceutical Sciences
658
mi
from 98109
Vallejo, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Longmont Clinic, PC
997
mi
from 98109
Longmont, CO
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Longmont Clinic, PC
997
mi
from 98109
Longmont, CO
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Western State Clinical Research Inc.
1014
mi
from 98109
Wheat Ridge, CO
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Western State Clinical Research Inc.
1014
mi
from 98109
Wheat Ridge, CO
Click here to add this to my saved trials